New Microbial Treatment to Protect Honeybees from Infection by American Foulbrood Disease


Invention Summary

A simple syrup can help deliver freeze-dried bacteriophages to honeybee larvae, effectively inoculating them against a harmful bacterium that causes American Foulbrood disease. In this process, a phage-filled capsule is mixed with syrup and supplied to a hive to facilitate a safe, natural distribution of the helpful microbes via nurse bees. This phage therapy is currently effective as a preventative measure but is also showing promise for eventual use as an early treatment for infected hives.


Market Opportunity

Millions of beehives owned by agricultural corporations, farmers, and beekeepers are at risk of contracting American Foulbrood disease. In order to save their hives – and the $15 billion in U.S. agriculture dependent on them for pollination – beekeepers can use this phage therapy to protect their hives from one of the most serious diseases contributing to Colony Collapse Disorder.


Features and Benefits

• Delivers helpful freeze-dried phages in capsule form


• Relies on environmentally friendly, natural process for distribution of beneficial microbes


• Preferable to chemical and antibiotic treatment methods


• Completely safe for bees and humans – an all-natural product


• Leaves no harmful residue behind in honey


Intellectual Property

Issued Patent 9,370,172

Patent Information:
Life Sciences
For Information, Contact:
John Minnick
Business Development Officer
University of Nevada, Las Vegas
Penny Amy
Diane Yost
Life Science - Agriculture
Life Science - Health
© 2024. All Rights Reserved. Powered by Inteum